SB 253 (2025)
Prohibit drug manufacturers from adding requirements related to 340B program
Summary:
Generally prohibits a drug manufacturer from denying or restricting acquisition or delivery of a 340B covered drug. According to the federal Government Accountability Office, the 340B Program requires drug manufacturers to sell outpatient drugs at discounted prices at some hospitals for those drugs to be covered by Medicaid.
Bill Became Law?:
No
Status:
Status Detail:
Killed in the Senate
Public Hearing Date:
02/19/2025 09:45 am
Public Hearing Location:
SH Room 100
Senate Voting Date:
03/06/2025
Want hearing dates, vote records or the full bill text? See more on the Statehouse website
https://gc.nh.gov/bill_status/billinfo.aspx?id=1113&inflect=2
Browse related articles and bills:
